aluates Reports

$ 0.0

Automative

Global Neurodegenerative Disease Treatment Drug Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-6M14422

Global Neurodegenerative Disease Treatment Drug Market Research Report 2023

BUY CHAPTERS

Global Neurodegenerative Disease Treatment Drug Market Research Report 2025

Code: QYRE-Auto-6M14422

Report

April 2025

Pages:63

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Amneal Pharmaceuticals, Inc.

Boehringer Ingelheim International GmbH

Hoffmann La Roche

Merck& Co. Inc

Neurodegenerative Disease Treatment Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Neurodegenerative Disease Treatment Drug Market

The global market for Neurodegenerative Disease Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Neurodegenerative Disease Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurodegenerative Disease Treatment Drug.

The Neurodegenerative Disease Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurodegenerative Disease Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neurodegenerative Disease Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Neurodegenerative Disease Treatment Drug Market Report

Report Metric	Details
Report Name	Neurodegenerative Disease Treatment Drug Market
CAGR	5%
Segment by Type	N-methyl-D-aspartate Receptor antagonists Cholinesterase Inhibitors Dopamine Agonists Immunomodulatory Drugs Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbvie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International Gmbh, Hoffmann-La Roche, Merck & Co. Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurodegenerative Disease Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neurodegenerative Disease Treatment Drug Market report?

Ans: The main players in the Neurodegenerative Disease Treatment Drug Market are Abbvie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International Gmbh, Hoffmann-La Roche, Merck & Co. Inc.

What are the Application segmentation covered in the Neurodegenerative Disease Treatment Drug Market report?

Ans: The Applications covered in the Neurodegenerative Disease Treatment Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Neurodegenerative Disease Treatment Drug Market report?

Ans: The Types covered in the Neurodegenerative Disease Treatment Drug Market report are N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Others

Recommended Reports

Neurodegenerative Diseases

Nervous System Drugs

Rare And Chronic Diseases

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 N-methyl-D-aspartate Receptor antagonists

1.2.3 Cholinesterase Inhibitors

1.2.4 Dopamine Agonists

1.2.5 Immunomodulatory Drugs

1.2.6 Others

1.3 Market by Application

1.3.1 Global Neurodegenerative Disease Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neurodegenerative Disease Treatment Drug Market Perspective (2020-2031)

2.2 Global Neurodegenerative Disease Treatment Drug Growth Trends by Region

2.2.1 Global Neurodegenerative Disease Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Neurodegenerative Disease Treatment Drug Historic Market Size by Region (2020-2025)

2.2.3 Neurodegenerative Disease Treatment Drug Forecasted Market Size by Region (2026-2031)

2.3 Neurodegenerative Disease Treatment Drug Market Dynamics

2.3.1 Neurodegenerative Disease Treatment Drug Industry Trends

2.3.2 Neurodegenerative Disease Treatment Drug Market Drivers

2.3.3 Neurodegenerative Disease Treatment Drug Market Challenges

2.3.4 Neurodegenerative Disease Treatment Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Neurodegenerative Disease Treatment Drug Players by Revenue

3.1.1 Global Top Neurodegenerative Disease Treatment Drug Players by Revenue (2020-2025)

3.1.2 Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Players (2020-2025)

3.2 Global Neurodegenerative Disease Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Neurodegenerative Disease Treatment Drug Revenue

3.4 Global Neurodegenerative Disease Treatment Drug Market Concentration Ratio

3.4.1 Global Neurodegenerative Disease Treatment Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neurodegenerative Disease Treatment Drug Revenue in 2024

3.5 Global Key Players of Neurodegenerative Disease Treatment Drug Head office and Area Served

3.6 Global Key Players of Neurodegenerative Disease Treatment Drug, Product and Application

3.7 Global Key Players of Neurodegenerative Disease Treatment Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Neurodegenerative Disease Treatment Drug Breakdown Data by Type

4.1 Global Neurodegenerative Disease Treatment Drug Historic Market Size by Type (2020-2025)

4.2 Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Type (2026-2031)

5 Neurodegenerative Disease Treatment Drug Breakdown Data by Application

5.1 Global Neurodegenerative Disease Treatment Drug Historic Market Size by Application (2020-2025)

5.2 Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Neurodegenerative Disease Treatment Drug Market Size (2020-2031)

6.2 North America Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025)

6.4 North America Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Neurodegenerative Disease Treatment Drug Market Size (2020-2031)

7.2 Europe Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025)

7.4 Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size (2020-2031)

8.2 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Neurodegenerative Disease Treatment Drug Market Size (2020-2031)

9.2 Latin America Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025)

9.4 Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size (2020-2031)

10.2 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbvie Inc.

11.1.1 Abbvie Inc. Company Details

11.1.2 Abbvie Inc. Business Overview

11.1.3 Abbvie Inc. Neurodegenerative Disease Treatment Drug Introduction

11.1.4 Abbvie Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)

11.1.5 Abbvie Inc. Recent Development

11.2 Amneal Pharmaceuticals Inc.

11.2.1 Amneal Pharmaceuticals Inc. Company Details

11.2.2 Amneal Pharmaceuticals Inc. Business Overview

11.2.3 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Introduction

11.2.4 Amneal Pharmaceuticals Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)

11.2.5 Amneal Pharmaceuticals Inc. Recent Development

11.3 Boehringer Ingelheim International Gmbh

11.3.1 Boehringer Ingelheim International Gmbh Company Details

11.3.2 Boehringer Ingelheim International Gmbh Business Overview

11.3.3 Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Introduction

11.3.4 Boehringer Ingelheim International Gmbh Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)

11.3.5 Boehringer Ingelheim International Gmbh Recent Development

11.4 Hoffmann-La Roche

11.4.1 Hoffmann-La Roche Company Details

11.4.2 Hoffmann-La Roche Business Overview

11.4.3 Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Introduction

11.4.4 Hoffmann-La Roche Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)

11.4.5 Hoffmann-La Roche Recent Development

11.5 Merck & Co. Inc.

11.5.1 Merck & Co. Inc. Company Details

11.5.2 Merck & Co. Inc. Business Overview

11.5.3 Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Introduction

11.5.4 Merck & Co. Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)

11.5.5 Merck & Co. Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Amneal Pharmaceuticals, Inc.

Boehringer Ingelheim International GmbH

Hoffmann La Roche

Merck& Co. Inc

List of Tables

Table 1. Global Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of N-methyl-D-aspartate Receptor antagonists

Table 3. Key Players of Cholinesterase Inhibitors

Table 4. Key Players of Dopamine Agonists

Table 5. Key Players of Immunomodulatory Drugs

Table 6. Key Players of Others

Table 7. Global Neurodegenerative Disease Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Neurodegenerative Disease Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Neurodegenerative Disease Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Neurodegenerative Disease Treatment Drug Market Share by Region (2020-2025)

Table 11. Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Neurodegenerative Disease Treatment Drug Market Share by Region (2026-2031)

Table 13. Neurodegenerative Disease Treatment Drug Market Trends

Table 14. Neurodegenerative Disease Treatment Drug Market Drivers

Table 15. Neurodegenerative Disease Treatment Drug Market Challenges

Table 16. Neurodegenerative Disease Treatment Drug Market Restraints

Table 17. Global Neurodegenerative Disease Treatment Drug Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Neurodegenerative Disease Treatment Drug Market Share by Players (2020-2025)

Table 19. Global Top Neurodegenerative Disease Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease Treatment Drug as of 2024)

Table 20. Ranking of Global Top Neurodegenerative Disease Treatment Drug Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Neurodegenerative Disease Treatment Drug Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Neurodegenerative Disease Treatment Drug, Headquarters and Area Served

Table 23. Global Key Players of Neurodegenerative Disease Treatment Drug, Product and Application

Table 24. Global Key Players of Neurodegenerative Disease Treatment Drug, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Neurodegenerative Disease Treatment Drug Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Type (2020-2025)

Table 28. Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Type (2026-2031)

Table 30. Global Neurodegenerative Disease Treatment Drug Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Application (2020-2025)

Table 32. Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Application (2026-2031)

Table 34. North America Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 49. Abbvie Inc. Company Details

Table 50. Abbvie Inc. Business Overview

Table 51. Abbvie Inc. Neurodegenerative Disease Treatment Drug Product

Table 52. Abbvie Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 53. Abbvie Inc. Recent Development

Table 54. Amneal Pharmaceuticals Inc. Company Details

Table 55. Amneal Pharmaceuticals Inc. Business Overview

Table 56. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Product

Table 57. Amneal Pharmaceuticals Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 58. Amneal Pharmaceuticals Inc. Recent Development

Table 59. Boehringer Ingelheim International Gmbh Company Details

Table 60. Boehringer Ingelheim International Gmbh Business Overview

Table 61. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Product

Table 62. Boehringer Ingelheim International Gmbh Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 63. Boehringer Ingelheim International Gmbh Recent Development

Table 64. Hoffmann-La Roche Company Details

Table 65. Hoffmann-La Roche Business Overview

Table 66. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Product

Table 67. Hoffmann-La Roche Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 68. Hoffmann-La Roche Recent Development

Table 69. Merck & Co. Inc. Company Details

Table 70. Merck & Co. Inc. Business Overview

Table 71. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Product

Table 72. Merck & Co. Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 73. Merck & Co. Inc. Recent Development

Table 74. Research Programs/Design for This Report

Table 75. Key Data Information from Secondary Sources

Table 76. Key Data Information from Primary Sources

Table 77. Authors List of This Report

List of Figures

Figure 1. Neurodegenerative Disease Treatment Drug Picture

Figure 2. Global Neurodegenerative Disease Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Neurodegenerative Disease Treatment Drug Market Share by Type: 2024 VS 2031

Figure 4. N-methyl-D-aspartate Receptor antagonists Features

Figure 5. Cholinesterase Inhibitors Features

Figure 6. Dopamine Agonists Features

Figure 7. Immunomodulatory Drugs Features

Figure 8. Others Features

Figure 9. Global Neurodegenerative Disease Treatment Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Neurodegenerative Disease Treatment Drug Market Share by Application: 2024 VS 2031

Figure 11. Hospital Case Studies

Figure 12. Clinic Case Studies

Figure 13. Others Case Studies

Figure 14. Neurodegenerative Disease Treatment Drug Report Years Considered

Figure 15. Global Neurodegenerative Disease Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Neurodegenerative Disease Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Neurodegenerative Disease Treatment Drug Market Share by Region: 2024 VS 2031

Figure 18. Global Neurodegenerative Disease Treatment Drug Market Share by Players in 2024

Figure 19. Global Top Neurodegenerative Disease Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease Treatment Drug as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Neurodegenerative Disease Treatment Drug Revenue in 2024

Figure 21. North America Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Neurodegenerative Disease Treatment Drug Market Share by Country (2020-2031)

Figure 23. United States Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Neurodegenerative Disease Treatment Drug Market Share by Country (2020-2031)

Figure 27. Germany Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Share by Region (2020-2031)

Figure 35. China Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Neurodegenerative Disease Treatment Drug Market Share by Country (2020-2031)

Figure 43. Mexico Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Share by Country (2020-2031)

Figure 47. Turkey Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Abbvie Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)

Figure 51. Amneal Pharmaceuticals Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)

Figure 52. Boehringer Ingelheim International Gmbh Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)

Figure 53. Hoffmann-La Roche Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)

Figure 54. Merck & Co. Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Neurologic Disorder Treatment Drug Market Research Report 2024

Alzheimer Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Central Nervous System Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs of Neuron Management Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alzheimer s Treatment Drug Market Research Report 2024

Neurology Digital Therapeutics Market

Global Alzheimer s Clinical Treatment Drug Market Research Report 2025

Central Nervous System Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Parkinson Treatment Drug Market Research Report 2025

Global Medicines for Alzheimer Disease Treatment Market Research Report 2025

Alzheimer Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prion Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alzheimer s Drugs Market Research Report 2025

Neurodegenerative Diseases Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI Assisted Diagnosis in Neurology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Early Diagnosis Kit For Alzheimer s Disease Market Research Report 2024

Global Tauopathies Treatment Market Research Report 2025

Brain Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alzheimer s Therapeutic Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions